Incyte

Pharmaceuticals

INCY

$ 60 (1.7)%

Share price

$ 13 bn

Market Cap

$ 9.9 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.02x the weighted average for S&P 500

FY2020

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Incyte reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 7.8 Kt (-1.3 /-14.5% y-o-y). Also positively, carbon intensity decreased to 2.9 t (-1.4 /-32.6% y-o-y).

Incyte's Scope 3 emissions was down at 0.82 Kt (-2.4 /-74.8% y-o-y).

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Date	Total CO2e emissions (location-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Scope 3	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2020Q4	7.8	0.77	7.1	0.82	2,667	2.9
2019Q4	9.2	1.6	7.6	3.3	2,159	4.3

Incyte

Carbon footprint

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Incyte's carbon footprint

Company environmental metrics